GTBP GT Biopharma Inc
Company Analysis
Latest News
🟢 GT Biopharma is trading 6.31% up today with no clear company-specific catalyst identified
GT Biopharma is trading at $0.31 (+6.31%) now, though no clear August 24, 2026 company-specific catalyst was identified. - The latest company release, dated...
🟢 GT Biopharma rises 5.3% — Biotech Sector Surges on Positive mRNA Cancer Vaccine Trial Results
With Biotech (XBI) up 3.7%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, proxied by the XBI ETF, is trading...
🟢 GT Biopharma is trading 8.57% up in pre-market with no confirmed catalyst
GT Biopharma is trading 8.57% up in pre-market at $0.30, after rising from the August 18, 2026 close of $0.28; no confirmed company-specific catalyst was...
🔴 GT Biopharma is trading 5.2% down today as Nasdaq Composite falls 1.31%
GT Biopharma is trading at $0.27, down 5.23%, amid broader market weakness. - No fresh company-specific announcement was identified on August 18, 2026. - The...
🟢 GT Biopharma is trading 7.1% up in pre-market after rebounding from its August 17, 2026 close
GT Biopharma is trading 7.1% up at $0.30 after rebounding from its August 17, 2026 close of $0.28. - No fresh company-specific announcement was identified on...
🟢 GT Biopharma is trading 7.1% up in pre-market
GT Biopharma is trading 7.1% up at $0.30 in pre-market after rebounding from its August 17, 2026 close of $0.28. - No fresh company-specific announcement...